Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

Market Cap	204.59B
Revenue (ttm)	68.81B
Net Income (ttm)	20.24B
Shares Out	886.45M
EPS (ttm)	22.83
PE Ratio	10.11
Forward PE	9.82
Dividend	10.50 (4.55%)
Ex-Dividend Date	n/a

Volume	209,271
Open	230.60
Previous Close	231.20
Day's Range	230.60 - 231.50
52-Week Range	197.20 - 249.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About SQURPHARMA

Square Pharmaceuticals PLC. and its subsidiaries develop, manufacture, and market drugs for health care for various live species in Bangladesh. The company offers generic pharmaceuticals, basic chemicals, and animal health products. It also markets crop care products. Square Pharmaceuticals PLC. also exports its products to approximately 42 countries. The company was founded in 1958 and is based in Dhaka, Bangladesh. Square Pharmaceuticals PLC. operates as a subsidiary of Square Group.

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 12,503
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SQURPHARMA

Financial Performance

In 2023, SQURPHARMA's revenue was 62.75 billion, an increase of 8.94% compared to the previous year's 57.60 billion. Earnings were 18.98 billion, an increase of 4.53%.